Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Premier Sponsors:  

Beckman Coulter Life Sciences 

Boston Healthcare

Cellecta  

Charles River Discovery

Elsevier 

 NanoString     

 SeraCare 

Silicon Biosystems   

 Streck 

 TriMetis


XIFIN

  View All Sponsors 


Cambridge Healthtech Institute’s Fourth Annual

PCR & NGS-Based Molecular Diagnostics

From Assay to FDA: Preparing PCR for Personalized Medicine

February 20-22, 2017 | Moscone North Convention Center | San Francisco, CA
Part of the 24th International Molecular Medicine Tri-Conference

 

Advances in molecular diagnostics technologies have sparked innovation, expanded research capabilities, and enhanced clinical diagnostics. Cambridge Healthtech Institute’s Fourth Annual PCR and NGS-Based Diagnostics puts an emphasis on the technologies that drive personalized medicine, from PCR and NGS to microarrays, and showcases how they are being used to alter clinical outcomes. This event will provide a comprehensive look at integrating molecular diagnostics solutions for biomarker discovery and development, point-of-care, companion diagnostics, and infectious disease. Molecular technologies will be compared and evaluated and case studies on getting regulatory approval will be shared. Overall, this event provides insight into advanced techniques and tools for effective disease diagnosis.

Who should attend: Vice Presidents, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Diagnostics, Business Development, R&D, Chemistry, Clinical Research, Personalized Healthcare, Process Development, and Oncology.

Topics may include, but are not limited to:

  • Technologies to drive personalized medicine
    • PCR, qPCR, dPCR
    • Next-Generation Sequencing (NGS)
    • Microarray

  • Comparison and standardization of methods
  • FDA guidance and rulings
  • Case studies on getting FDA approval
  • Molecular-based POC tests
  • Companion diagnostics
  • Cancer molecular markers
  • Antimicrobial susceptibility testing

If you would like to submit a proposal to give a presentation at this meeting, please click here.  

The deadline for submission is July 15, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Samantha Drinkwater
Senior Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5461
E: sdrinkwater@healthtech.com

Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com